Tirzepatide versus other agents

Where it leads, where it trails, and what comes next

No drug exists in isolation. Tirzepatide is measured against semaglutide today and against a wave of next-generation agents arriving soon. This unit lays out the comparisons honestly: the metabolic edge tirzepatide holds, the areas where semaglutide still leads, and the pipeline that may eventually surpass both.

The goal is a balanced scorecard, not a cheerleading exercise, so you can judge claims about "the best" incretin drug for yourself.